https://www.selleckchem.com/products/jsh-150.html
Xenograft tumorigenicity assay was performed to assess the effect of FZD2 on tumor growth in vivo. FZD2 mRNA and protein expression was abundant in BC tissues. Moreover, high level of FZD2 had significant correlation with poor prognosis in BC patients. In vitro functional assays revealed that silencing of FZD2 had suppressive effects on BC cell growth, migration and invasion. Animal study further demonstrated that FZD2 silencing inhibited BC cell growth in vivo. In addition, FZD2 induced EMT process in BC cells in a transforming growth
Like
Comment
Share
